Immune recognition of protein antigens relies on the combined interaction of multiple antibody loops, which provide a fairly large footprint and constrain the size and shape of protein surfaces that can be targeted. Single protein loops can mediate extremely high-affinity binding, but it is unclear whether such a mechanism is available to antibodies. Here we report the isolation and characterization of an antibody called C05, which neutralizes strains from multiple subtypes of influenza A virus, including H1, H2 and H3. X-ray and electron microscopy structures show that C05 recognizes conserved elements of the receptor-binding site on the haemagglutinin surface glycoprotein. Recognition of the haemagglutinin receptor-binding site is dominated by a single heavy-chain complementarity-determining region 3 loop, with minor contacts from heavy-chain complementarity-determining region 1, and is sufficient to achieve nanomolar binding with a minimal footprint. Thus, binding predominantly with a single loop can allow antibodies to target small, conserved functional sites on otherwise hypervariable antigens.
Antibody recognition of protein antigens is predominantly mediated by four to six complementarity-determining regions (CDRs), which are the variable loops at the tip of each Fab. The relatively large footprint of antibodies on their target antigens (,700-900 Å 2 for proteins) generally correlates with high-affinity binding. However, for neutralizing antibodies against variable pathogens, a larger footprint may result in increased opportunity for escape mutations that reduce antibody binding. Moreover, functionally conserved sites on otherwise variable antigens may be small, as for the influenza virus receptor-binding site; partially protected by glycans, as with both the HIV-1 glycoprotein gp120 and influenza; or are sterically restricted and difficult for antibodies to access, such as the picornavirus 'canyon' 1 or the gp120 co-receptor-binding site on HIV-1 (ref. 2) . By contrast, non-immunoglobulin proteins can also achieve highaffinity binding in other ways that may have distinct advantages for targeting small, constrained surfaces. For example, bovine pancreatic trypsin inhibitor (BPTI) attains exceptionally high-affinity binding (K d at fM levels) to serine proteases by inserting a single loop into the enzyme active site 3 . In light of the increasingly long heavy-chain CDR3 (HCDR3) loops being found in humans [4] [5] [6] , a BPTI-like binding mechanism may be structurally accessible to antibodies, allowing insertion of a single loop into a pocket. However, no clear example of an antibody using such a binding mechanism has been reported.
Two conserved and functionally important sites on the haemagglutinin (HA) stem have been targeted by antibodies previously, including epitopes recognized by the broadly neutralizing antibodies A06 (refs 7 and 8) , CR6261 (refs 9 and 10), F10 (ref. 11), CR8020 (ref. 12) and FI6 (ref. 13) . Several recent studies have suggested that stem antibodies may be present in a greater number of individuals than previously thought 14, 15 , and the ability to re-elicit stem antibodies by immunization 16 has raised hopes that a universal vaccine for influenza A may be achievable. Although such antibodies against the stem are highly cross-reactive, most antibodies that target the more variable receptor-binding domain (RBD) of the HA1 subunit show limited breadth of neutralization. Crystal structures show that, although a few antibody footprints on the HA1 RBD sometimes coincide with the receptor-binding site [17] [18] [19] [20] , many of the essential interactions are made with hypervariable regions well outside of the functionally conserved region involved in sialic acid recognition 21, 22 . However, recent work suggests that some rare antibodies against the HA1 RBD can achieve modest cross-reactivity 20, 23, 24 . Thus, identification and structural understanding of heterosubtypic antibodies against the RBD with broad activity, particularly against human pandemic viruses (influenza H1, H2 and H3 subtypes), would be a major advance and facilitate development of new therapeutics complementary to those targeting the stem. Here we report the functional and structural characterization of one such antibody, C05, which neutralizes multiple subtypes by inserting an extended CDR loop into the receptorbinding pocket.
Isolation and characterization of C05
Previously, we isolated antibodies from phage-displayed combinatorial libraries derived from Turkish patients who survived H5N1 avian flu infection 7, 8 and identified a new class of antibodies effective against a broad range of group 1 influenza A viruses. Here we used a similar approach to identify antibodies that would neutralize both group 1 and group 2 viruses. Phage libraries constructed from the immune repertoires of seasonal influenza infection survivors were doubly selected against HA proteins from H1 (group 1) and H3 (group 2). This process yielded a limited number of clones that reacted broadly with both H1 and H3 HA proteins. One clone, C05, which uses the V H 3-23 and Vk1-33*01 heavy-and light-chain V genes, respectively, has two distinctive structural features: a long 24-amino-acid HCDR3 ( Supplementary  Fig. 1 ) and a five-residue somatic insertion in HCDR1. C05 potently neutralizes viruses from H1, H2, H3 and H9 subtypes in vitro ( Fig. 1 and Table 1a ), including the influenza A subtypes that have caused human pandemics. However, C05 had no detectable activity against the H5 subtype, as well as some of the H1 viruses tested. In sharp contrast to most broadly neutralizing antibodies to influenza [9] [10] [11] 25 , which bind the more conserved stem region, C05 inhibits receptor binding and haemagglutination (Table 1a) , indicating recognition of an epitope in the HA1 globular head domain.
Protection in vivo
To explore the in vivo efficacy of C05, we examined its ability to protect mice from lethal challenge with H1N1 or H3N2 viruses. When administered prophylactically 24 h before challenge with the A/Memphis/3/2008 (H1N1) virus, 1 mg kg 21 C05 IgG protected 100% of mice from death and prevented substantial weight loss (Fig. 2a) . Lower doses (0.025-0.25 mg kg
21
) still afforded proportional protection ( Supplementary Fig. 2a ). For the A/X-31/1968 (H3N2) virus, a 10 mg kg 21 dose protected 100% of the mice from death (Fig. 2b) , and both 0.25 and 1.0 mg kg 21 doses afforded protection to the majority ( Supplementary Fig. 2b ).
Next we determined the therapeutic potential of C05 against an established H1N1 or H3N2 infection. A single 15 mg kg 21 IgG dose was administered at 1, 2, 3, 4 or 5 days after lethal challenge with the aforementioned H1N1 or H3N2 viruses. In both instances, mice treated up to 3 days after infection were completely protected (Fig. 2c, d ). We then evaluated the minimal dose needed to overcome established infection 3 days after inoculation, the latest time at which C05 treatment was completely protective against death. As little as a single 3 mg kg 21 dose of antibody prevented infection-related death in 80% of the animals ( Supplementary Fig. 2c ). These in vivo results indicate the utility of C05 in both prevention and treatment.
Avidity is critical for C05 function
To further profile its breadth of activity, we tested C05 Fab binding to a large panel of HAs by biolayer interferometry (BLI), including representative members of most of the 16 influenza subtypes. C05 Fab binds to a number of diverse HAs spanning both group 1 and group 2 viruses, including members of the H1, H2, H3, H9 and H12 subtypes (Table 1b) . Notably, many HAs from viruses neutralized by IgG C05 are bound with only intermediate-to-low affinity by the Fab (K d , 100 nM-10 mM), well outside the range typically required for effective neutralization, such as by stem antibodies (K d , 100 nM) 10, 12 . To confirm these unexpected results, we selected four HAs from neutralized viruses that bound C05 Fab with a range of affinities (K d 5 18 nM, 430 nM, 720 nM, and one with no detectable Fab binding by BLI) and assessed C05 binding in solution by isothermal titration calorimetry (ITC). The ITC results were in good agreement with the K d measured by BLI (Table 1c) . Notably, (Table 1c) . Thus, despite the unusually low affinity of C05 Fab for many of its targets, C05 IgG potently neutralizes virus replication in vitro and is protective in vivo. To the best of our knowledge, only one other neutralizing antibody has been reported with such a considerable discrepancy between binding affinity and neutralization. The broadly neutralizing anti-HIV antibody 2G12 binds a high-mannose glycan cluster on the gp120 subunit of the HIV surface spike, but its affinity for a single high-mannose glycan is very low (K d at mM levels) 26 . However, a highly unusual domain-swapping of the Fabs allows 2G12 to bind multiple glycans simultaneously and thereby achieve high-affinity binding (nM levels) through avidity 27 . For C05, the presence of multiple antibody-binding sites on each trimeric HA spike and the high density of HA on the virus surface may facilitate simultaneous engagement of both arms of the C05 IgG, resulting in much higher avidity compared with Fab. Electron microscopy experiments with H1, H2 and H3 HAs show that three C05 Fabs are bound per trimer (Fig. 3f) , but their geometry is inconsistent with bivalent attachment by an IgG antibody. Indeed, C05 IgG binds to an array of immobilized HA with much higher affinity (nM to ,pM levels) than its Fab, consistent with the single-particle electron microscopy analysis confirming the ability of IgG to cross-link HA spikes (Supplementary Fig. 3 ). Thus, some antibodies with low-affinity Fab interactions can still have strong activity in vitro and in vivo and may represent an under-appreciated component of the immune repertoire. The role of avidity may be more or less pronounced depending on the nature of the epitope and the density of the antigen on the viral surface, with clustered epitopes, such as those on the HA1 RBD, benefiting most from avidity, whereas sterically crowded (for example, HA stem) or sparse epitopes (HIV envelope spikes) probably prevent bivalent binding. In the latter case, high-affinity binding must be achieved by the Fab or by heteroligation of two different antigens, which may have a more prominent role in the neutralization of human viruses such as HIV 28 .
Crystal structure of the C05-HA complex
To understand how the antibody C05 achieves heterosubtypic neutralization, we determined the crystal structure of C05 Fab in complex with the HA1 subunit from the A/Hong Kong/1/1968 (HK68/H3) influenza strain at 2.95 Å resolution, and Fab C05 in complex with the complete, trimeric ectodomain of HK68/H3 at 4.25 Å (Supplementary Table 1 ). In addition, high-resolution structures of HK68/H3 HA (1.90 Å ) and C05 Fab (2.30 Å ) provided high-quality starting models for refinement of the complexes. Few differences are apparent between the isolated HA1 and the HA1 subunit in trimeric HA, as in other HA1 crystal structures 18 . Further, the C05-HA1 and C05-HA trimer structures are in excellent Supplementary Fig. 4 ), indicating that the C05-HA1 complex faithfully recapitulates the native interaction.
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Three C05 Fabs bind near the membrane-distal end of the HA trimeric spike (Fig. 3a) , and HCDR3 penetrates the receptor-binding site (Fig. 3b) . Several notable features of the C05 interaction are immediately apparent, and the exceptionally long 24-residue HCDR3 of C05 dominates the antibody-antigen interaction (Fig. 3b) . Although ,1.5% of human antibodies in the Abysis database have an HCDR3 of 24 or more residues, only 3 of the over 1,000 Fab structures in the Protein Data Bank have more than 24-residue HCDR3s (Supplementary Fig. 5 ). Very long CDRs can adopt unusual conformations, such as the 'hammerhead' structure in PG9 and PG16 4, 6, 29 , and these long loops are presumably crucial for antigen recognition, yet few structures of such antibodies bound to antigen have been reported. The C05 structure therefore gives us a valuable glimpse at how long HCDR3s can be used to target recessed or evolutionarily constrained epitopes.
The long HCDR3 of C05 extends far from the antibody surface, with its most distal end forming a b-hairpin. The long HCDR3 holds the V H and V L domains at a distance from the HA surface (Fig. 3c) , preventing the light chain from contacting the epitope, reminiscent of the heavy-chain-dominant recognition by stem-directed V H 1-69 antibodies 9, 11 . At a first approximation, the C05 HCDR3 resembles the PG9 and PG16 hammerheads, but with its shorter carboxyterminal branch truncated ( Supplementary Fig. 6 ). The HCDR3 b-hairpin inserts into the shallow HA receptor-binding pocket near the HA spike apex (Fig. 3d ). HCDR3 overlaps with the binding site for glycan receptors, indicating that C05 inhibits virus attachment by direct competition with sialic acid (Fig. 3e) . However, C05 interaction with the receptor-binding site differs considerably from sialic acid binding to HA.
Aside from HCDR3, only HCDR1 makes additional minor interactions with HA, in part owing to a five-residue somatic insertion ( Fig. 3g and Supplementary Fig. 1 ). Insertions and deletions (indels) within the V gene coding region are relatively rare 30, 31 , but recent work suggests that these indels may be selected during affinity maturation and can be important for antibody function 32, 33 . Consistent with the minor contacts made by HCDR1, removal of the five-residue insert (del(FGEST)) or scanning mutagenesis of HCDR1 had no detectable effect on C05 binding to HK68/H3 and several other H1, H2 and H3 HAs (Table 2 and Supplementary Table 2 ), whereas binding of C05(del(FGEST)) to the HA of H3 influenza subtype strain Perth09 was reduced nearly 100-fold compared with wild-type C05 ( Table 2 ), indicating that HCDR1 may make additional interactions with Perth09 (see discussion in Supplementary Information and Supplementary Fig. 7) . Thus, the HCDR1 insertion is dispensable for binding to most HAs tested, whereas the HCDR3 loop alone is sufficient for full activity. However, nearby antibody CDRs and framework regions probably contribute to binding by supporting HCDR3, as the loop conformation is essentially identical in the crystal structure of C05 Fab alone. In particular, the tip of HCDR2 interacts with the Fig. 8 ). By contrast, HCDR1 seems to have a lesser role, as the above mutations above did not prevent C05 binding.
Loop-insertion binding mechanism
Despite high sequence diversity immediately surrounding the receptorbinding site, the functional constraints imposed by binding to sialic acid receptors restrict variation within the pocket itself. Thus, although other antibodies can bind in or near the receptor-binding site, a typical antibody footprint would extend well beyond the conserved functional region and contact at least some variable positions around the receptorbinding site, rendering them largely strain specific and susceptible to escape through antigenic drift. A notable exception is CH65, which cross-neutralizes an unusually large subset of H1N1 viruses, but not other subtypes 20 . However, unlike C05, CH65 binds HA using both heavy and light chains (including five of the six CDR loops), which increases contact with these more variable surfaces ( Supplementary  Fig. 9 ). By contrast, the long HCDR3 of C05 targets the conserved elements of the receptor-binding site, and enters and exits the pocket without contacting many of the surrounding variable positions (Fig. 4a,  b) . Indeed, we were unable to generate C05 escape mutants with an H3 virus despite repeated attempts.
Loop insertion is a common mechanism for achieving high-affinity protein-protein interactions, as notably illustrated by BPTI 3 . Owing to the restricted, single-CDR-driven interaction of C05 with HK68/ H3 HA, only 550 Å 2 of surface area is buried on the HA by C05, which is unusually small for an antibody-protein interaction. This small footprint allows C05 to achieve broader cross-reactivity compared with other antibodies that extend their interface outside of the receptorbinding site (for example, ,650 Å 2 buried surface on HA for CH65 and 740 Å 2 for 2D1; Supplementary Table 3) . Single-particle threedimensional electron microscopy reconstructions of C05 bound to H1, H2 and H3 HAs (Fig. 3f and Supplementary Fig. 10 ), along with binding experiments probing the effect of several mutations in the HCDR3 loop ( Supplementary Fig. 11 ), clearly illustrate that binding to other subtypes is probably very similar to that in the H3 crystal structure.
Epitope conservation and variation linked to escape
The wide range of affinities for C05 against a panel of HAs indicates that epitope variation has a considerable effect on C05 activity. Therefore, we examined that sequence diversity contained within all full-length, non-redundant human H1, H2 and H3 HA sequences in the NCBI Flu database 34 . An analysis including all 16 virus subtypes yielded similar results (Supplementary Table 4 ). Of 17 C05 contact residues on HA, 6 core residues are $99% conserved across human H1, H2 and H3 viruses, including 98, 134, 136, 153, 190 and 194 (Fig. 4a, b) . The remaining 11 positions are generally ,50% conserved (ranging from 42 to 76%). Therefore, the C05 epitope is markedly less conserved (mean % identity/mean % conservation across all contact residues is 59%/64%) compared with stem epitopes recognized by broadly neutralizing antibodies (76%/86% for CR6261 and 71%/ 80% for CR8020), owing to greater variation within the receptorbinding site. Thus, the range of observed affinities for C05 binding to H3 HAs may arise from multiple, subtle mutations (increasing K d two-to tenfold) that in combination tune C05 affinity for HA and ultimately reduce binding below the threshold of detection in some cases. Substitutions at HA1 190, 225, 226 and 228 are important for determining receptor specificity in HAs adapted to particular hosts (for example, a2-3 versus a2-6 sialoglycans for avian versus human viruses, respectively), and mutations modulating receptor affinity are a well-documented mechanism of antibody escape 35 . C05 makes only minor contacts with Leu 226 and does not contact residues 225 or 228. C05 interacts more extensively with Asp 190 in HK68/H3, but Asp, Glu and Val are present at position 190 in our panel of HAs bound by C05. Thus, C05 may bind equally well to HAs with either a2,3 or a2,6 receptor specificity, but variability within the receptor-binding site may account for some of the observed heterogeneity in C05 binding.
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L100k L100k Fig. 12 ). These insights have enabled us to delineate the most important structural requirements for highaffinity cross-reactive binding to the receptor-binding site.
Implications for antiviral therapeutics and vaccine design
Because C05 binding is accomplished exclusively through the heavy chain, and primarily through HCDR3, its interaction with HA defines a minimal set of contacts sufficient for cross-group neutralization, which may be exploited to develop antiviral therapeutics. The ability of a broadly neutralizing antibody, such as C05, to penetrate the shallow receptor-binding site with relatively high affinity (mM to nM levels) and avidity (nM) compared with its natural receptor (mM) makes such an antibody extremely attractive for therapeutics and diagnostics. C05 was discovered from a single human donor source library using the power of phage-display library technology to isolate this rare antibody-binding interaction. Owing to the combinatorial nature of antibody library construction, we cannot determine explicitly whether the C05 heavy chain and light chain pairing previously existed in the donor. However, other receptor-binding site antibodies, such as CH65 (ref. 20) , have been isolated from B cells, showing that receptor-binding site antibodies can be found naturally and are potentially inducible by vaccination strategies. Thus, the design of HA immunogens to elicit more broadly neutralizing head antibodies may now be more feasible and will complement the arsenal of already promising stem antibodies for use in a more universal vaccine, as well as in structure-based and computational approaches to design small proteins and other possible therapeutics against flu, such as already achieved against the stem epitope
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. Structure determination. Robotic crystal screening was carried out using the Rigaku Crystalmation system at the Joint Center for Structural Genomics. Diffraction data were collected at the Advanced Photon Source GM/CA-CAT 23ID-B and 23ID-D and SSRL 11-1 beamlines and processed using HKL2000 (HKL Research) and XPREP (Bruker). Structures were solved by molecular replacement using Phaser, adjusted using Coot and refined in Phenix. Kabat numbering was applied using Abnum 37 . Structural analyses were performed using programs MS and CONTACSYM. Sequences. PDB antibody sequences were analysed through the Abysis database. HA sequence data sets were downloaded from the NCBI Flu database 34 , aligned with MUSCLE 38 and analysed using Genetics Computer Group (Accelrys) and custom shell scripts.
METHODS SUMMARY
Full Methods and any associated references are available in the online version of the paper. Enzyme-linked immunosorbent assay (ELISA)-inactivated virus was incubated overnight at room temperature (20-22 uC) . The next day plates were blocked (1% bovine serum albumin in PBS buffer and 0.05% Tween-20) and 0.1 ml serum samples (diluted in blocking buffer) were incubated, washed and detected using a peroxidase-conjugated anti-human Fc antibody (Jackson ImmunoResearch) and tetramethyl benzidine detection (BioFX). Attenuance at D 450 nm was read, and data recorded is reported herein. Library construction. Antibody phage-display libraries were created from the individual immune repertoires of confirmed influenza infection survivors. Bone marrow aspirates were collected and stored in RNAlater (Ambion) to preserve RNA integrity until processing for library construction. Serum samples were taken from each individual and used to confirm antibody reactivity to various HA proteins or inactivated influenza viruses by ELISA (Supplementary Fig. 13 ). The phage-display libraries were constructed as previously described in ref. IgG expression and Fabs. The C05 heavy-and light-chain regions were mammalian-codon-optimized, synthesized (GeneArt) and cloned into the pTT5-based expression vectors. Expression was done essentially as described in ref. 7 . The C05 Fab fragment was obtained by Lys-C digestion of IgG, followed by purification by protein A (GE Healthcare), protein G (GE Healthcare), cation exchange (MonoS, GE Healthcare) and gel filtration (Superdex 200, GE Healthcare). For binding studies, C05 Fab was expressed recombinantly using the baculovirus system. A DNA fragment derived from the promoter region of pFastBac-Dual (Invitrogen) was fused to the gp67 and the honey bee melittin (HBM) signal peptides by overlap PCR, yielding a fragment with head-to-head p10 and polyhedrin promoters upstream of the HBM and gp67 signal peptides, respectively (that is, HBM-p10-pPolyH-gp67). C05 Fab heavy-and light-chain regions were synthesized (GenScript), fused to the promoter-signal peptide cassette by overlap PCR (heavy chain downstream of pPolyH-gp67 and light chain downstream of p10-HBM) and ligated into the SfiI sites of a derivative of pFastBacDual. A His 6 tag was introduced at the C terminus of the light chain to facilitate purification.
METHODS
Mutations to probe the importance of the CDR H1 insertion were generated by site-directed mutagenesis using the QuikChange Lightning Multi kit (Agilent). The resulting baculovirus transfer vectors were used to generate recombinant bacmids using the Bac-to-Bac system (Invitrogen) and virus was rescued by transfecting purified bacmid DNA into Sf9 cells using Cellfectin II (Invitrogen). C05 Fab proteins were produced by infecting suspension cultures of Hi5 cells (Invitrogen) with recombinant baculovirus at a multiplicity of infection (MOI) of 5-10 and incubating at 28 uC, shaking at 110 r.p.m. After 72 h, the cultures were clarified by two rounds of centrifugation at 2,000g and 10,000g at 4 uC. The supernatant containing secreted, soluble Fab was concentrated and buffer exchanged into 1 3 PBS, pH 7.4. After metal-affinity chromatography using nickel-nitrilotriacetic acid (Ni-NTA) resin, Fabs were purified by protein G affinity chromatography (GE Healthcare) and gel filtration (Superdex 200). ELISA. Microtitre plates were coated with 0.1 ml of the following HA antigens diluted in coating buffer and incubated overnight at room temperature: 100 ng ml 21 H5N1 Vietnam 1203/04, 700 ng ml 21 H1N1 New Caledonia/20/99 and 100 ng ml 21 H3N2 Wisconsin/67/05. Blocking was done with 0.3 ml of blocking buffer (4% non-fat dry milk in PBS and 0.05% Tween-20). After blocking, antibodies were diluted to 0.5 mg ml 21 in 2% non-fat dry milk blocking buffer and were incubated for 2 h at 4 uC, washed and later detected using a 1:3,000 dilution of peroxidase-conjugated anti-human Fc antibody (Jackson ImmunoResearch) in 2% non-fat dry milk blocking buffer and standard TMB substrate detection. Attenuance at D 450 nm was read, and data recorded are reported herein. Viruses. Recombinant influenza viruses were generated using reverse genetics as previously described in ref. 39 . In brief, 1 mg each of ten plasmids was transfected into 293T cells in monolayer. Each transfection contained ambisense plasmids (for the expression of both viral RNAs and messenger RNAs) for the A/Puerto Rico/8/34/PA, PB1, PB2, NP, M and NS segments, in addition to viral RNA (pPOL1 type) and protein expression plasmids (pCAGGS type) for A/X-31/ 1968 HA and NA (pCAGGS expression plasmid was kindly provided by J. Miyazaki 40 ). Twenty hours after transfection, 293T cells were re-suspended in cell culture supernatant and used to inoculate 10-day-old embryonated eggs. Microneutralization. Antibodies were screened for neutralizing activity against viruses as follows. Twofold serial dilutions of each monoclonal antibody were incubated with 100 50% tissue culture infective doses of virus in PBS at 37 uC for 1 h. Madin-Darby canine kidney cell monolayers in 24-well plates were washed once with PBS and inoculated with virus-antibody mixtures. After incubation for 1 h at 37 uC in 5% CO 2, the inoculum was removed and monolayers were again washed once with PBS. Opti-MEM supplemented with 0.3% BSA, 0.01% FBS and 1 mg ml 21 tosyl phenylalanyl chloromethyl ketone-treated trypsin was added and cells were incubated for 72 h at 37 uC. The presence of virus in cell culture supernatants was assessed by HA assays using 0.5% chicken red blood cells. Haemagglutination inhibition. Haemagglutination-inhibition titres were determined using four haemagglutinating units of HA protein or virus. HA protein or virus was incubated for 1 h at room temperature with serial twofold dilutions of C05 IgG in 96-well, V-bottom microtitre plates (Costar) followed by addition of 0.5% chicken red blood cells and mixing. The mixture was incubated for 30 min at room temperature followed by brief centrifugation at 1,000 r.p.m. to pellet the red blood cells. Mice were 5-6-week-old BALB/c for the H1N1 studies and DBA/2 for the H3N2 studies. Cloning, expression and purification of influenza A HAs. On the basis of H3 numbering, complementary DNAs corresponding to residues 11-329 (HA1) and 1-176 (HA2) of the influenza A HA ectodomain were fused to an amino-terminal gp67 signal peptide and to a C-terminal biotinylation site (amino acid sequence: GGGLNDIFEAQKIEWHE), trimerization domain and His 6 -tag by overlap PCR, essentially as previously described in ref. 12 . The trimerization domain and His 6 -tag were separated from the HA ectodomain by a thrombin cleavage site. In the case of the HK68/H3 trimer construct used for crystallization, the biotinylation site was omitted from the construct. For the HK68/HA1 subunit used for crystallization, HA1 residues 43-309 were fused to the gp67 signal peptide (N terminus) and a C-terminal His 6 -tag. The resulting PCR products were digested with SfiI and inserted into a custom baculovirus transfer vector (pDCE198). The production of virus and expression conditions were essentially as above for the C05 Fabs. After metal-affinity chromatography using Ni-NTA resin, trimeric HAs for crystallography were digested with trypsin (New England Biolabs, 5 mU trypsin per mg HA, 16 h at 17 uC) to produce uniformly cleaved (HA1/HA2), and to remove the trimerization domain and His 6 -tag. After quenching the digests with 2 mM phenylmethylsulphonyl fluoride, the digested material was further purified by anion-exchange chromatography (MonoQ, GE Healthcare, 10 mM Tris, pH 9.0, 50-1,000 mM NaCl) and size-exclusion chromatography (Superdex 200, GE Healthcare, 10 mM Tris, pH 8.0, 150 mM NaCl). Expression and purification of BirA. Escherichia coli biotin ligase (BirA enzyme) was expressed and purified in a manner similar to previous reports 41 , but with an N-terminal His tag, essentially as previously described in ref. 12 . In brief, a pET21a derivative containing the E. coli birA gene (pDCE095) was transformed into BL21(DE3) cells, grown in shake flasks in low salt LB medium at 37 uC to an attenuance (at D 600 nm ) of ,0.7, then shifted to 23 uC and induced with the addition of isopropyl-b-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM. The culture was incubated at 23 uC for ,16 h after induction. The cells were lysed and homogenized by two passes through an EmulsiFlex C-3 cell disruptor (15kPSI), and birA was purified by nickel affinity (NiNTA resin, Qiagen), anion exchange (MonoQ column, GE Healthcare) and gel filtration. Purified BirA protein was concentrated to 5 mg ml 21 in 50 mM Tris, pH 7.5, 200 mM potassium chloride and 5% glycerol, aliquoted, flash frozen in liquid nitrogen and stored at 280 uC.
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Biotinylation and purification of influenza HAs for binding studies. After expression and Ni-NTA purification of influenza A HA as described above, proteins for binding studies were concentrated to ,2-5 mg ml 21 total protein. The HAs were biotinylated by the addition of 25 mg BirA enzyme per mg total protein, in a buffer of the following composition: 100 mM Tris, pH 8.0, 10 mM ATP, 10 mM magnesium acetate and 50 mM biotin, with less than 50 mM NaCl. The biotinylation reactions were incubated at 37 uC for 1-2 h. Biotinylated HAs were purified by size-exclusion chromatography and concentrated to ,5-20 mg ml 21 . K d determination by BLI. K d was determined by BLI using an Octet Red instrument (ForteBio). Biotinylated HAs, purified as described above, were used for these measurements. HAs at ,10-50 mg ml 21 in 13 kinetics buffer ( K d determination by ITC. ITC was performed using an ITC 200 calorimeter (Microcal). All proteins were dialysed extensively against PBS buffer before the titrations. The experiments were performed at 25 uC. A typical titration consisted of injecting 1.6 ml aliquots of C05 Fab (0.5 mM) into 70 mM HA solution in the cell at time intervals of 90 s to ensure that the titration peak returned to the baseline. ITC data were corrected for the heat of dilution by subtracting the mixing enthalpies for titrant solution injections into protein-free buffer. ITC data were analysed using program Origin (Version 7.0) as provided by the manufacturer using a single set of identical binding sites model.
Owing to the high molecular weight of the system and the very poor expression of the A/Brisbane/10/2007 (H3N2) HA, we were unable to achieve a high enough molar concentration of HA in the ITC cell to obtain a complete, high-quality titration curve. For a K d of 10 mM, the manufacturer's guidelines suggest 0.5 mM HA in the cell and 5 mM Fab in the syringe. This would correspond to ,30 mg ml 21 HA (,10 mg total) and ,250 mg ml 21 Fab (,20 mg total). However, we were only able to obtain ,1 mg of the A/Brisbane/10/2007 (H3N2) HA from 10 l of insect cell culture, precluding the possibility of obtaining the quantity of protein required for an optimal experiment. In addition, although C05 Fab could be obtained in good yields and could be concentrated to at least 50 mg ml 21 (,1 mM), clear self-association between C05 molecules was apparent even at ,19 mg ml 21 (,0.38 mM), the concentrations used in the experiment reported here. However, after subtraction of Fab injections into a buffer-filled cell to correct for the heat of dilution resulting from the Fab self-association at high concentrations, the resulting data could still be fit reasonably well and an approximate value for the K d could be obtained (see Supplementary Fig. 16 ). Electron microscopy of C05 Fab with H1, H2 and H3 HAs. Negative-stained grids were prepared by applying 0.1 mg ml 21 of the purified complex to a freshly glow-discharged carbon-coated 400 Cu mesh grid and stained with Nano-W. Grids were viewed using a FEI Tecnai TF20 electron microscope operating at an accelerating voltage of 120 kV and imaged at a magnification of 3100,000. Images were acquired on a Gatan 4k 3 4k charge-coupled device (CCD) camera in five-degree tilt increments from 0 to 55u using a de-focus range of 700 to 900 nm. The tilt angles provided additional particle orientations to improve the image reconstruction. The pixel size of the CCD camera was calibrated at this magnification to be 1.09 Å using a two-dimensional catalase crystal with known cell parameters. Image processing. For each complex, particles were automatically selected from micrographs using the DoG Picker software through the Appion package 42, 43 . The contrast transfer function estimation for micrographs was completed using ctffind3 and ctfttilt 42, 44 . Particles were binned by four (80 3 80-sized boxes) and reference free two-dimensional class averages were calculated using the Sparx package, without imposing symmetry 45 . An unliganded 25Å hemagglutinin (H1) volume generated with Sparx was used as the initial model for the image reconstruction process, with the reference-free class averages as the experimental images. Density for the Fabs could be visualized after 3 cycles of refinement. Refinement was continued for 70 cycles with decreasing angular search parameters. The resultant model was then used as the initial model for the iterative image reconstruction process against the raw particles binned by two (160 3 160-sized boxes). Contrast transfer function correction was applied during this procedure using the Sparx package. C3 symmetry was imposed throughout the image reconstruction process. The final three-dimensional image reconstructions have an estimated resolution of 17 Å according to a Fourier shell correlation (FSC) of 0.5. Model fitting. Coordinates of HA from A/Solomon Islands/3/2006 (H1N1) and A/Japan/305/1957 (H2N2) in addition to C05 were fitted into the respective electron microscopy reconstructions. For H3, the coordinates of HA from A/Hong Kong/1/1968 (H3N2) were used in the electron microscopy reconstruction of HA from A/Perth/16/2009 (H3N2) with C05 Fab. The automated fit of each component was manually improved through rigid body movement using the program UCSF Chimera to minimize the number of clashes between HA and the Fabs while maintaining the highest possible correlation coefficient value with the chimera fit tool. This resulted in a portion at the base of the stem region of HA being excluded from the image reconstruction. Coincidentally, this region of HA possesses high B-factors in the crystal structures and may adopt distinct conformations on the electron microscope grid. The density for this region can be seen at lower contour thresholds. Crystallization and structure determination of the HK68/H3 HA. Gelfiltration fractions containing HK68/H3 HA were concentrated to ,9 mg ml 21 in 10 mM Tris, pH 8.0, and 50 mM NaCl. Initial crystallization trials were set up using the automated Rigaku CrystalMation robotic system at the Joint Center for Structural Genomics (http://www.jcsg.org). The crystal used for data collection was grown by the sitting drop vapour diffusion method with a reservoir solution (200 ml) containing 2.0 M ammonium sulphate, 100 mM sodium cacodylate, pH 6.5, and 200 mM NaCl. Drops consisting of 100 nl protein 1 100 nl precipitant were set up at 20 uC, and crystals appeared within 3-7 days. The resulting crystals were cryoprotected by brief immersion in well solution supplemented with 35% glycerol, then flash-cooled and stored in liquid nitrogen until data collection.
Diffraction data for the HK68/H3 HA were collected on beamline 11-1 at the SSRL. The data were indexed in space group C222 1 , integrated and scaled using HKL2000 (HKL Research). The structure was solved by molecular replacement to 1.90 Å resolution using Phaser 46 . A protomer from 2VIU 18 (A/X-31/1968 (H3N2) HA) was used as the initial search model and three copies (forming a noncrystallographic trimer) were found in the asymmetric unit. At this point, poorly defined regions of the model were trimmed and the HA was mutated in silico to match the HK68/H3 sequence. Rigid body refinement, simulated annealing and restrained refinement (including translation-libration-screw (TLS) refinement, with one group for each HA1 or HA2 domain) were carried out in Phenix 47 . Riding hydrogens were used during refinement and are included in the final model. Between rounds of refinement, the model was built and adjusted using Coot 48 . Waters were built automatically using the 'ordered_solvent' modelling function in Phenix 47 . Refinement statistics can be found in Supplementary  Table 1 . Crystallization and structure determination of the C05 Fab. Gel-filtration fractions containing the C05 Fab were concentrated to ,11 mg ml 21 in 10 mM Tris, pH 8.0, and 50 mM NaCl. Initial crystallization trials were set up using the automated Rigaku CrystalMation robotic system at the Joint Center for Structural Genomics (http://www.jcsg.org). Several hits were obtained, with the most promising candidates grown in ,2.0-2.5 M ammonium sulphate between pH 5 and 7. Optimization of these conditions resulted in diffraction-quality crystals. The crystals used for data collection were grown by the sitting drop vapour diffusion method with a reservoir solution (1 ml) containing 1.8 M ammonium sulphate, 100 mM sodium acetate, pH 5.4, and 50 mM NaCl. Drops consisting of 0.5 ml protein 1 0.5 ml precipitant were set up at 4 uC and crystals appeared within 3-7 days. The resulting crystals were cryoprotected by soaking in well solution supplemented with increasing concentrations of ethylene glycol (5% steps, 1 h per step) to a final concentration of 20%, then flash-cooled and stored in liquid nitrogen until data collection.
Diffraction data for the C05 Fab crystals were collected on the GM/CA-CAT 23ID-D beamline at the Advanced Photo Source (APS) at Argonne National Laboratory. The data were indexed in space group P4 1 2 1 2, integrated, scaled, and merged using HKL2000 (HKL Research). The structure was solved by molecular replacement to 2.30 Å resolution using Phaser 46 . PDB codes 1AQK and 1VGE were used as search models for the variable and constant domains, respectively, and 2 complete Fabs were found in the asymmetric unit. Rigid body refinement, simulated annealing and restrained refinement (including TLS refinement, with one group for each Ig domain) were carried out in Phenix 47 . Riding hydrogens were used during refinement and are included in the final model. Between rounds of refinement, the model was built and adjusted using Coot 48 . Waters were built automatically using the 'ordered_solvent' modelling function in Phenix 47 . Refinement statistics can be found in Supplementary  Table 1. RESEARCH ARTICLE
